Posted: 1 month(s) and 13 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: crwepicks

Please Visit CRWEPicks.ning.com

February 5, 2010

GETA is a biopharmaceutical company with a diversified product portfolio Genta Incorporated is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company’s research platform: DNA/RNA-based Medicines and Small Molecules. Genasense® (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program.

_________________

PWRM is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power 3 Medical Products Inc., has patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets, and its diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas and continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer's, and Parkinson's diseases, breast cancer, and drug resistance.

_________________

CRWE has a new office to expand its operations. Crown Equity Holding Inc. is a growing company, and has relocated to a new and larger executive office bulding. The new corporate address is located at, 5440 W. Sahara Avenue. Suite 205, Las Vegas, Nevada 89146.

***********************************

************Advertisement************

************************************

Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our sites, newsletters or emails unless you can afford to lose your entire investment. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.Com and/or Crown Equity Holdings, Inc., its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site nor do they represent the views or opinions of the Crown Equity Holdings, Inc.

Member Rating: 0 0